Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3 - PubMed (original) (raw)
. 2003 Nov 15;171(10):5498-506.
doi: 10.4049/jimmunol.171.10.5498.
Affiliations
- PMID: 14607956
- DOI: 10.4049/jimmunol.171.10.5498
Free article
Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3
Yolande Chvatchko et al. J Immunol. 2003.
Free article
Abstract
Chemokines play a key role in the recruitment of activated CD4(+) T cells and eosinophils into the lungs in animal models of airway inflammation. Inhibition of inflammation by N-terminally modified chemokines is well-documented in several models but is often reported with limited dose regimens. We have evaluated the effects of doses ranging from 10 ng to 100 micro g of two CC chemokine receptor antagonists, Met-RANTES/CC chemokine ligand 5 (CCL5) and aminooxypentane-RANTES/CCL5, in preventing inflammation in the OVA-sensitized murine model of human asthma. In the human system, aminooxypentane-RANTES/CCL5 is a full agonist of CCR5, but in the murine system neither variant is able to induce cellular recruitment. Both antagonists showed an inverse bell-shaped inhibition of cellular infiltration into the airways and mucus production in the lungs following allergen provocation. The loss of inhibition at higher doses did not appear to be due to partial agonist activity because neither variant showed activity in recruiting cells into the peritoneal cavity at these doses. Surprisingly, neither was able to bind to the major CCR expressed on eosinophils, CCR3. However, significant inhibition of eosinophil recruitment was observed. Both analogues retained high affinity binding for murine CCR1 and murine CCR5. Their ability to antagonize CCR1 and CCR5 but not CCR3 was confirmed by their ability to prevent RANTES/CCL5 and macrophage inflammatory protein-1beta/CCL4 recruitment in vitro and in vivo, while they had no effect on that induced by eotaxin/CCL11. These results suggest that CCR1 and/or CCR5 may be potential targets for asthma therapy.
Similar articles
- Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.
Proudfoot AE, Buser R, Borlat F, Alouani S, Soler D, Offord RE, Schröder JM, Power CA, Wells TN. Proudfoot AE, et al. J Biol Chem. 1999 Nov 5;274(45):32478-85. doi: 10.1074/jbc.274.45.32478. J Biol Chem. 1999. PMID: 10542293 - Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
Elsner J, Dulkys Y, Kimmig D, Wells TN, Proudfoot AE, Kapp A. Elsner J, et al. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):227-9. doi: 10.1159/000053719. Int Arch Allergy Immunol. 2001. PMID: 11306977 - Differential activation of CC chemokine receptors by AOP-RANTES.
Elsner J, Mack M, Brühl H, Dulkys Y, Kimmig D, Simmons G, Clapham PR, Schlöndorff D, Kapp A, Wells TN, Proudfoot AE. Elsner J, et al. J Biol Chem. 2000 Mar 17;275(11):7787-94. doi: 10.1074/jbc.275.11.7787. J Biol Chem. 2000. PMID: 10713092 - CC-chemokine receptors in chronic obstructive pulmonary disease.
Bracke KR, Demedts IK, Joos GF, Brusselle GG. Bracke KR, et al. Inflamm Allergy Drug Targets. 2007 Jun;6(2):75-9. doi: 10.2174/187152807780832292. Inflamm Allergy Drug Targets. 2007. PMID: 17692030 Review. - Targeting CCL5 in inflammation.
Marques RE, Guabiraba R, Russo RC, Teixeira MM. Marques RE, et al. Expert Opin Ther Targets. 2013 Dec;17(12):1439-60. doi: 10.1517/14728222.2013.837886. Epub 2013 Oct 3. Expert Opin Ther Targets. 2013. PMID: 24090198 Free PMC article. Review.
Cited by
- Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells.
Banerjee A, Damera G, Bhandare R, Gu S, Lopez-Boado Y, Panettieri R Jr, Tliba O. Banerjee A, et al. Br J Pharmacol. 2008 Sep;155(1):84-92. doi: 10.1038/bjp.2008.232. Epub 2008 Jun 16. Br J Pharmacol. 2008. PMID: 18552877 Free PMC article. - Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation.
Zhou LF, Zhu Y, Cui XF, Xie WP, Hu AH, Yin KS. Zhou LF, et al. Respir Res. 2006 Dec 20;7(1):146. doi: 10.1186/1465-9921-7-146. Respir Res. 2006. PMID: 17178007 Free PMC article. - The functional antagonist Met-RANTES: a modified agonist that induces differential CCR5 trafficking.
Kiss DL, Longden J, Fechner GA, Avery VM. Kiss DL, et al. Cell Mol Biol Lett. 2009;14(4):537-47. doi: 10.2478/s11658-009-0017-1. Epub 2009 May 14. Cell Mol Biol Lett. 2009. PMID: 19448977 Free PMC article. - The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections.
Kohlmeier JE, Miller SC, Smith J, Lu B, Gerard C, Cookenham T, Roberts AD, Woodland DL. Kohlmeier JE, et al. Immunity. 2008 Jul 18;29(1):101-13. doi: 10.1016/j.immuni.2008.05.011. Immunity. 2008. PMID: 18617426 Free PMC article. - Met-CCL5 represents an immunotherapy strategy to ameliorate rabies virus infection.
Huang Y, Jiao S, Tao X, Tang Q, Jiao W, Xiao J, Xu X, Zhang Y, Liang G, Wang H. Huang Y, et al. J Neuroinflammation. 2014 Aug 21;11:146. doi: 10.1186/s12974-014-0146-y. J Neuroinflammation. 2014. PMID: 25182681 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous